logo

For the Inventor, By the Inventor

Exton, PA, United States of America

Christen M Giandomenico

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Johnson Matthey Inc., Anormed, Inc.. Active years: 1989-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christen M Giandomenico. Retrieved from https://idiyas.com/inventor/christen-m-giandomenico

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0


Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 145(Granted Patents)


Location History:

  • Exton, PA (US) (1989 - 2001)
  • Blaine, WA (US) (2002 - 2005)

Company Filing History:

goldMedal6 out of 269 
 
Johnson Matthey Inc.
 patents
silverMedal3 out of 40 
 
Anormed, Inc.
 patents

Years Active: 1989-2005

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 6894049 - Platinum complexes as antitumor agents (2005-05-17),
2. 6489472 - Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof (2002-12-03),
3. 6217845 - Protein labelling (2001-04-17),
4. 5753520 - Protein labelling (1998-05-19),
5. 5420285 - Protein labelling utilizing certain pyridyl hydrazines, hydrazides and (1995-05-30),
6. 5244919 - Pt(IV) complexes as anti-tumor agents (1993-09-14),
7. 5100885 - Copper radiosensitizers (1992-03-31),
8. 5072011 - Pt(IV) complexes (1991-12-10),
9. 4851403 - Radiation sensitizers (1989-07-25),

Title: Innovator Christen M Giandomenico: Pioneering Antitumor Agents

Introduction

Christen M Giandomenico is a notable inventor based in Exton, Pennsylvania. He has made significant contributions to the field of chemistry, particularly in the development of platinum-based antitumor agents. With a total of nine patents to his name, Giandomenico's work has the potential to impact cancer treatment significantly.

Latest Patents

Among his latest patents, Giandomenico has developed platinum complexes as antitumor agents. This invention focuses on platinum antitumor drugs, specifically platinum complexes characterized by unique formulas. Another notable patent involves a process for the preparation of N-1 protected N ring nitrogen-containing cyclic polyamines. This process allows for high yields in protecting cyclic polyamines containing N nitrogens on the ring, utilizing specific fluoro-containing agents that facilitate easy deprotection.

Career Highlights

Throughout his career, Giandomenico has worked with prominent companies such as Johnson Matthey Inc. and Anormed, Inc. His experience in these organizations has contributed to his expertise in the field of chemical innovations.

Collaborations

Giandomenico has collaborated with esteemed colleagues, including Michael J Abrams and David Aaron Schwartz. These partnerships have likely enriched his research and development efforts.

Conclusion

Christen M Giandomenico's innovative work in the field of antitumor agents showcases his dedication to advancing cancer treatment. His patents reflect a commitment to scientific progress and collaboration within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…